These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 808791)

  • 1. Reliability of the Booth-Nadler technique for the detection of Hunter heterozygotes.
    Donnelly PV; Di Ferrante N
    Pediatrics; 1975 Sep; 56(3):429-33. PubMed ID: 808791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterozygote detection in Hunter syndrome.
    Zlotogora J; Bach G
    Am J Med Genet; 1984 Mar; 17(3):661-5. PubMed ID: 6424473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of the heterozygous state in Hunter's syndrome.
    Booth CW; Nadler HL
    Pediatrics; 1974 Mar; 53(3):396-9. PubMed ID: 4273646
    [No Abstract]   [Full Text] [Related]  

  • 4. Female twin with Hunter disease due to nonrandom inactivation of the X-chromosome: a consequence of twinning.
    Winchester B; Young E; Geddes S; Genet S; Hurst J; Middleton-Price H; Williams N; Webb M; Habel A; Malcolm S
    Am J Med Genet; 1992 Dec; 44(6):834-8. PubMed ID: 1481858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of Hunter syndrome (mucopolysaccharidosis type II) in Taiwanese: biochemical and linkage studies of the iduronate-2-sulfatase gene defects in MPS II patients and carriers.
    Lin SP; Chang JH; Lee-Chen GJ; Lin DS; Lin HY; Chuang CK
    Clin Chim Acta; 2006 Jul; 369(1):29-34. PubMed ID: 16480701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The defect in Hurler and Hunter syndromes. II. Deficiency of specific factors involved in mucopolysaccharide degradation.
    Fratantoni JC; Hall CW; Neufeld EF
    Proc Natl Acad Sci U S A; 1969 Sep; 64(1):360-6. PubMed ID: 4244031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined enzymatic and linkage analysis for heterozygote detection in Hunter syndrome: identification of an apparent case of germinal mosaicism.
    Ben Simon-Schiff E; Bach G; Zlotogora J; Abeliovich D
    Am J Med Genet; 1993 Nov; 47(6):837-42. PubMed ID: 7904121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability of the Tønnesen technique for the identification of Hunter carriers.
    Petruschka L; Machill G; Wehnert M; Seidlitz G; Knapp A
    Hum Genet; 1983; 64(4):404-6. PubMed ID: 6413387
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mucopolysaccharidosis II (Hunter syndrome): identification of the carrier state of the disease by means of mutation analysis].
    Balzano N; Villani GR; Coppa G; Di Natale P
    Pediatr Med Chir; 1996; 18(1):91-3. PubMed ID: 8685031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of fructose 1-phosphate to detect Hunter heterozygotes in fibroblast cultures from high-risk carriers.
    Tønnesen T
    Hum Genet; 1984; 66(2-3):212-6. PubMed ID: 6425196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Hurler and Hunter syndromes.
    Dorfman A; Matalon R
    Am J Med; 1969 Nov; 47(5):691-707. PubMed ID: 4243120
    [No Abstract]   [Full Text] [Related]  

  • 12. Prenatal monitoring for the Hunter syndrome: the heterozygous female fetus.
    Kleijer WJ; Moody PD; Liebaers I; van de Kamp JJ; Niermeijer MF
    Clin Genet; 1979 Feb; 15(2):113-7. PubMed ID: 153809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hunter disease in a girl caused by R468Q mutation in the iduronate-2-sulfatase gene and skewed inactivation of the X chromosome carrying the normal allele.
    Sukegawa K; Song XQ; Masuno M; Fukao T; Shimozawa N; Fukuda S; Isogai K; Nishio H; Matsuo M; Tomatsu S; Kondo N; Orii T
    Hum Mutat; 1997; 10(5):361-7. PubMed ID: 9375851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of the use of fructose 1-phosphate to detect Hunter cells in fibroblast-cultures of obligate carriers of the Hunter syndrome.
    Tønnesen T; Güttler F; Lykkelund C
    Hum Genet; 1983; 64(4):371-5. PubMed ID: 6225723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hunter-Hurler syndrome. A prototype for the study of storage disease.
    Julius R; Aylsworth A; Rennert O
    J Fla Med Assoc; 1970 Sep; 57(9):23-5. PubMed ID: 4247390
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro selection for the Hunter gene.
    Booth CW; Nadler HL
    N Engl J Med; 1973 Mar; 288(12):636. PubMed ID: 4631420
    [No Abstract]   [Full Text] [Related]  

  • 17. I-cell disease, mucolipidosis II. Pathological, histochemical, ultrastructural and biochemical observations in four cases.
    Gilbert EF; Dawson G; zu Rhein GM; Opitz JM; Spranger
    Z Kinderheilkd; 1973; 114(4):259-92. PubMed ID: 4353613
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and molecular analysis in a patient with the severe form of Hunter syndrome after bone marrow transplantation.
    Li P; Thompson JN; Hug G; Huffman P; Chuck G
    Am J Med Genet; 1996 Sep; 64(4):531-5. PubMed ID: 8870917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retinal histological changes in mucopolysaccharidosis of the Hunter type. (Preliminary note)].
    Danis P; Toussaint D
    Bull Soc Belge Ophtalmol; 1971; 157(2):365-73. PubMed ID: 4258332
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal diagnosis of the Hunter syndrome and the introduction of a new fluorimetric enzyme assay.
    Keulemans JL; Sinigerska I; Garritsen VH; Huijmans JG; Voznyi YV; van Diggelen OP; Kleijer WJ
    Prenat Diagn; 2002 Nov; 22(11):1016-21. PubMed ID: 12424767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.